Delivery Order SPE2DB22D3011-SPE2DB23FQ0TF

Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $22K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $15,047.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,560,996,710 units of Topiramate 25 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Cencora, Inc. The $1,441.31 Firm Fixed Price Delivery Order is for 4,563,008,896 tablets of the medication Topiramate 200 mg, with a completion date of December 7, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award is for the delivery of Topiramate 25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $5,411.40 and a completion date of February 23, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating full and open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,364.62 firm fixed-price delivery order is for the supply of 4,563,416,702 units of Topiramate 25 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award, with an ID of SPE2DB22D1202|SPE2DB24FUTC1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4,563,906,174 units of Topiramate 25 mg tablets in quantities of 500 per bottle. The contract has a firm fixed price of $5,388.95 and a completion date of March 11, 2024. This is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 25 mg Topiramate tablets. The firm fixed price delivery order has a ceiling value of $26,627.50 and a performance period through April 8, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp (DUNS TGxsdkVQRGhOYUpNR001SHhYREdNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of 4,564,977,351 units of Topiramate 25 mg tablets. The firm-fixed-price delivery order has a ceiling value of $1,815.09 and a completion date of June 24, 2024. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,179,886 units of Topiramate 25 mg tablets. The $5,960.24 delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to AmerisourceBergen Drug Corp by DLA. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,417,391 units of Topiramate 25 mg tablets in lots of 1,000, with a total ceiling value of $1,062.72. This is a Firm Fixed Price Delivery Order contract with a completion date of January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,906.02 firm fixed-price delivery order is for the supply of 500 tablets of Topiramate 25 mg, a prescription medication. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB23FQ0TF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $21,558.02, is for the delivery of 4560750062 Topiramate 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2023.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract is not designated as a set-aside.

Generated 5/9/25, 10:24 AM